#news #biotech AcelRx crushed, again, after FDA knocks back pain drug

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: AcelRx crushed, again, after FDA knocks back pain drug .AcelRx Pharmaceuticals is in the doghouse with investors yet again. The latest, 60% hit to AcelRx’s stock price followed another run-in with the FDA, which knocked back a filing for approval of pain drug Dsuvia.

from FierceBiotech: Biotech http://ift.tt/2gyOpXF